Impact and effectiveness of risk mitigation strategies on the insurability of nanomaterial production: Evidences from industrial case studies

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 7, Issue 6, 2015, Pages 839-855

  Bergamaschi, Enrico ^a   Murphy, Finbarr ^b   Poland, Craig A ^c   Mullins, Martin ^b   Costa, Anna L ^d   Mcalea, Eamonn ^b   Tran, Lang ^c   Tofail, Syed A M ^e  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF LIMERICK   (Ireland)

^c INSTITUTE OF OCCUPATIONAL MEDICINE   (United Kingdom)

^d INSTITUTE OF SCIENCE AND TECHNOLOGY FOR CERAMICS   (Italy)

^e UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HAZARDS; INSURANCE; MANUFACTURE; MULTIWALLED CARBON NANOTUBES (MWCN); OXIDE MINERALS; RISK ASSESSMENT; TITANIUM DIOXIDE; ZIRCONIA;

FUTURE APPLICATIONS; GENERAL POPULATION; INDUSTRIAL CASE STUDY; INSURANCE COMPANIES; MANUFACTURING PLANT; MATERIAL PERFORMANCE; PRODUCTION PROCESS; RISK MITIGATION STRATEGY;

LIFE CYCLE;

MULTI WALLED NANOTUBE; NANOCOATING; NANOMATERIAL; TITANIUM DIOXIDE NANOPARTICLE; CARBON NANOTUBE; METAL; NANOPARTICLE;

ARTICLE; CASE STUDY; CONTROLLED STUDY; INDUSTRIAL MEDICINE; METHODOLOGY; PERFORMANCE; PRIORITY JOURNAL; RISK FACTOR; CHEMISTRY; ENVIRONMENTAL EXPOSURE; HUMAN; INDUSTRY; NANOTECHNOLOGY; OCCUPATIONAL EXPOSURE; PARTICLE SIZE; PROCEDURES; RISK ASSESSMENT; SAFETY;

ENVIRONMENTAL EXPOSURE; HUMANS; INDUSTRY; METALS; NANOPARTICLES; NANOSTRUCTURES; NANOTECHNOLOGY; NANOTUBES, CARBON; OCCUPATIONAL EXPOSURE; PARTICLE SIZE; RISK ASSESSMENT; SAFETY;

EID: 84943752936     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1340     Document Type: Article

References (56)

1. Schulte P, Geraci C, Murashov V, Kuempel E, Zumwalde R, Castranova V, Hoover M, Hodson L, Martinez K. Occupational safety and health criteria for responsible development of nanotechnology. J Nanopart Res 2014, 16:1-17.
2. Renn O, Roco M. Nanotechnology Risk Governance. Geneva: The International Risk Governance Council; 2006.
3. ISO/TS 12901-2:2014. Nanotechnologies - occupational risk management applied to engineered nanomaterials - Part 2: use of the control banding approach. Geneva, Switzerland: International Organization for Standardization; 2011.
4. Savolainen K, Backman U, Brouwer D, Fadeel B, Fernandes T, Kuhlbusch T, Landsiedel R, Lynch I, Pylkkänen L. Nanosafety in Europe 2015-2025: Towards Safe and Sustainable Nanomaterials and Nanotechnology Innovations. Helsinki: Finnish Institute of Occupational Health; 2013.
5. Kuempel ED, Geraci CL, Schulte PA. Risk assessment and risk management of nanomaterials in the workplace: translating research to practice. Ann Occup Hyg 2012, 56:491-505.
6. Mullins M, Murphy F, Baublyte L, McAlea EM, Tofail SA. The insurability of nanomaterial production risk. Nat Nanotechnol 2013, 8:222-224.
7. Hubbs AF, Sargent LM, Porter DW, Sager TM, Chen BT, Frazer DG, Castranova V, Sriram K, Nurkiewicz TR, Reynolds SH, et al. Nanotechnology: toxicologic pathology. Toxicol Pathol 2013, 41:395-409.
8. Winkler DA, Mombelli E, Pietroiusti A, Tran L, Worth A, Fadeel B, McCall MJ. Applying quantitative structure-activity relationship approaches to nanotoxicology: current status and future potential. Toxicology 2013, 313:15-23.
9. Donaldson K, Schinwald A, Murphy F, Cho WS, Duffin R, Tran L, Poland C. The biologically effective dose in inhalation nanotoxicology. Acc Chem Res 2012, 46:723-732.
10. Abbott LC, Maynard AD. Exposure assessment approaches for engineered nanomaterials. Risk Anal 2010, 30:1634-1644.
11. Clark K, van Tongeren M, Christensen FM, Brouwer D, Nowack B, Gottschalk F, Micheletti C, Schmid K, Gerritsen R, Aitken R. Limitations and information needs for engineered nanomaterial-specific exposure estimation and scenarios: recommendations for improved reporting practices. J Nanopart Res 2012, 14:1-14.
12. Brouwer DH, van Duuren-Stuurman B, Berges M, Bard D, Jankowska E, Moehlmann C, Pelzer J, Mark D. Workplace air measurements and likelihood of exposure to manufactured nano-objects, agglomerates, and aggregates. J Nanopart Res 2013, 15:1-14.
13. ISO/TS 27687:2008. Terminology and definitions for nano-objects-nanoparticle, nanofibre and nanoplate. Genève, Switzerland: International Organization for Standardization; 2008.
14. Esch RK, Han L, Foarde KK, Ensor DS. Endotoxin contamination of engineered nanomaterials. Nanotoxicology 2010, 4:73-83.
15. Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
16. Bianchia MG, Allegri M, Costa AL, Blosi M, Gardini D, Del Pivo C, Prina-Mello A, Di Cristo L, Bussolati O, Bergamaschi E. Titanium dioxide nanoparticles enhance macrophage activation by LPS through a TLR4-dependent intracellular pathway. Toxicol Res 2015, 4:385-398. DOI: 10.1039/c4tx00193a
17. Fadeel B, Feliu N, Vogt C, Abdelmonem AM, Parak WJ. Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013, 5:111-129.
18. Monopoli MP, Åberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 2012, 7:779-786.
19. Lynch I, Weiss C, Valsami-Jones E. A strategy for grouping of nanomaterials based on key physico-chemical descriptors as a basis for safer-by-design NMs. Nano Today 2014, 9:266-270.
20. Paik SY, Zalk DM, Swuste P. Application of a pilot control banding tool for risk level assessment and control of nanoparticle exposures. Ann Occup Hyg 2008, 52:419-428.
21. Zalk DM, Paik SY, Swuste P. Evaluating the control banding nanotool: a qualitative risk assessment method for controlling nanoparticle exposures. J Nanopart Res 2009, 11:1685-1704.
22. Groso A, Petri-Fink A, Magrez A, Riediker M, Meyer T. Management of nanomaterials safety in research environment. Part Fibre Toxicol 2010, 7:1-8.
23. ANSES (2010) Development of a specific control banding tool for nanomaterials. French Agency for Food, Environmental and Occupational Health and Safety. No 2008-SA-0407, Còrdoba
24. Van Duuren-Stuurman B, Vink SR, Verbist KJ, Heussen HG, Brouwer DH, Kroese DE, Tielemans E, Fransman W. Stoffenmanager nano version 1.0: a web-based tool for risk prioritization of airborne manufactured nano objects. Ann Occup Hyg 2012, 56:525-541.
25. Brouwer DH. Control banding approaches for nanomaterials. Ann Occup Hyg 2012, 56:506-514.
26. Hamilton RF, Wu N, Porter D, Buford M, Wolfarth M, Holian A. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part Fibre Toxicol 2009, 6:35.
27. Costa AL. A Rational Approach for the Safe Design of Nanomaterials. In Nancy A. Monteiro-Riviere NA, Tran LC, eds Nanotoxicology: Progress toward Nanomedicine. CRC Press, Boca Raton, FL; 2014 37-44.
28. NIOSH. Current intelligence bulletin 63: occupational exposure to titanium dioxide. Washington, D.C.: National Institute of Occupational Safety and Health; 2011
29. SECO. State Secretariat for Economic Affairs, Chemicals and Occupational Health Safety data sheet (SDS): guidelines for synthetic nanomaterials. State Secretariat for Economic Affairs, Zurich; 2012.
30. Saxena V, Diaz A, Clearfield A, Batteas JD, Hussain MD. Zirconium phosphate nanoplatelets: a biocompatible nanomaterial for drug delivery to cancer. Nanoscale 2013, 5:2328-2336.
31. G. Garnweitner, Zirconia nanomaterials: synthesis and biomedical application. Nanotechnologies for the Life Sciences 2009. 10.1002/9783527610419.ntls0144
32. Sayama K, Arakawa H. Photocatalytic decomposition of water and photocatalytic reduction of carbon dioxide over zirconia catalyst. J Phys Chem 1993, 97:531-533.
33. Mohr U, Ernst H, Roller M, Pott F. Pulmonary tumor types induced in Wistar rats of the so-called "19-dust study". Exp Toxicol Pathol 2006, 58:13-20.
34. Cho WS, Duffin R, Thielbeer F, Bradley M, Megson IL, Macnee W, Poland CA, Tran CL, Donaldson K. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal-oxide nanoparticles. Toxicol Sci 2012, 126:469-477.
35. Methner M, Hodson L, Dames A, Geraci C. Nanoparticle emission assessment technique (NEAT) for the identification and measurement of potential inhalation exposure to engineered nanomaterials-Part B: results from 12 field studies. J Occup Environ Hyg 2010, 7:163-176.
36. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 93 - Carbon Black, Titanium dioxide, and Talc. International Agency for Research on Cancer, LYON, FRANCE, 2010.
37. Fenoglio I, Greco G, Livraghi S, Fubini B. Non-UV-induced radical reactions at the surface of tio2 nanoparticles that may trigger toxic responses. Chemistry 2009, 15:4614-4621.
38. Shukla RK, Sharma V, Pandey AK, Singh S, Sultana S, Dhawan A. ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells. Toxicol In Vitro 2011, 25:231-241.
39. Shukla RK, Kumar A, Gurbani D, Pandey AK, Singh S, Dhawan A. TiO2 nanoparticles induce oxidative DNA damage and apoptosis in human liver cells. Nanotoxicology 2013, 7:48-60.
40. NIOSH - National Institute for Occupational Safety and Health. Occupational Exposure to Titanium Dioxide. Current Intelligence Bulletin n. 63. Department of Health and Human Services. Centers for Disease Control and Prevention, 2011.
41. 2 based photocatalytic coatings: from nanostructure to functional properties. Chem Eng J 2013, 225:880-886.
42. 2 based nano-photocatalysis immobilized on cellulose substrates. J Photochem Photobiol A Chem 2013, 276:58-64.
43. Kayat J, Gajbhiye V, Tekade RK, Jain NK. Pulmonary toxicity of carbon nanotubes: a systematic report. Nanomedicine 2011, 7:40-49.
44. Mercer RR, Scabilloni JF, Hubbs AF, Battelli LA, McKinney W, Friend S, Wolfarth MG, Andrew M, Castranova V, Porter DW. Distribution and fibrotic response following inhalation exposure to multi-walled carbon nanotubes. Part Fibre Toxicol 2013, 10:33.
45. Porter DW, Hubbs AF, Chen BT, McKinney W, Mercer RR, Wolfarth MG, Battelli L, Wu N, Sriram K, Leonard S. Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology 2013, 7:1179-1194.
46. Wang P, Nie X, Wang Y, Li Y, Ge C, Zhang L, Wang L, Bai R, Chen Z, Zhao Y. Multiwall carbon nanotubes mediate macrophage activation and promote pulmonary fibrosis through TGF-β/Smad signaling pathway. Small 2013, 9:3799-3811.
47. Shvedova AA, Tkach AV, Kisin ER, Khaliullin T, Stanley S, Gutkin DW, Star A, Chen Y, Shurin GV, Kagan VE. Carbon nanotubes enhance metastatic growth of lung carcinoma via Up-regulation of myeloid-derived suppressor cells. Small 2013, 9:1691-1695.
48. Murphy-Pérez E, Arya SK, Bhansali S. Vapor-liquid-solid grown silica nanowire based electrochemical glucose biosensor. Analyst 2011, 136:1686-1689.
49. Poland CA, Byrne F, Cho W-S, Prina-Mello A, Murphy FA, Davies GL, Coey J, Gounko Y, Duffin R, Volkov Y. Length-dependent pathogenic effects of nickel nanowires in the lungs and the peritoneal cavity. Nanotoxicology 2012, 6:899-911.
50. Donaldson K, Murphy FA, Duffin R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010, 7:5.
51. Ma-Hock L, Strauss V, Treumann S, Kuttler K, Wohlleben W, Hofmann T, Groters S, Wiench K, van Ravenzwaay B, Landsiedel R. Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black. Part Fibre Toxicol 2013, 10:23.
52. Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Schwegler-Berry D, Castranova V, Porter DW. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre Toxicol 2010, 7:28.
53. Murphy F, Poland C, Duffin R, Al-Jamal K, Ali-Boucetta H, Nunes A. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol 2011, 178:2587-2600.
54. Schinwald A, Murphy F, Prina-Mello A, Poland C, Byrne F, Movia D. The threshold length for fiber-induced acute pleural inflammation: shedding light on the early events in asbestos-induced mesothelioma. Toxicol Sci 2012, 128:461-470.
55. WHO. Determination of airborne fibre number concentrations. A recommended method, by phase-contrast optical microscopy membrane filter method. Geneva, Switzerland: World Health Organization; 1997.
56. Morose G. The 5 principles of "design for safer nanotechnology". J Clean Prod 2010, 18:285-289.